☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Bayer Reports sNDA Submission to US FDA and MAA to EMA for Copanlisib + Rituximab to Treat B-iNHL and Relapsed MZL
June 22, 2021
Arrowhead Signs a License Agreement with Horizon to Develop siRNA Therapeutic Targeting XDH for Uncontrolled Gout
June 22, 2021
Innovent Publishes the Results of Sintilimab + IBI305 (bevacizumab- biosimilar) in P-II/III ORIENT-32 Study as 1L Treatment for HC...
June 22, 2021
AstraZeneca and MSD's Koselugo (selumetinib) Receive the EU's Approval for Neurofibromatosis Type 1 and Plexiform Neurofibromas
June 22, 2021
ViiV Healthcare Signs a License Agreement with Halozyme for ENHANZE Drug Delivery Technology to Develop Ultra Long-Acting Medicine...
June 22, 2021
GSK and Vir Report Results of Sotrovimab in P-III COMET-ICE Trial for High-Risk Adult Patients with Mild-To-Moderate COVID-19
June 22, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions